Molecure S.A. (WSE:MOC)
8.68
+1.26 (16.98%)
Jan 28, 2026, 5:00 PM CET
Molecure Market Cap
Molecure has a market cap or net worth of 152.88 million as of January 28, 2026. Its market cap has decreased by -3.09% in one year.
Market Cap
152.88M
Enterprise Value
136.00M
Revenue
5.86M
Ranking
n/a
PE Ratio
n/a
Stock Price
8.68
Market Cap Chart
Since April 19, 2018, Molecure's market cap has decreased from 338.43M to 152.88M, a decrease of -54.83%. That is a compound annual growth rate of -9.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 27, 2026 | 152.88M | 12.42% |
| Dec 30, 2025 | 135.98M | -20.03% |
| Dec 30, 2024 | 170.04M | -48.21% |
| Dec 29, 2023 | 328.30M | 64.10% |
| Dec 30, 2022 | 200.07M | -61.66% |
| Dec 30, 2021 | 521.79M | -24.18% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Apr 19, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ryvu Therapeutics | 612.68M |
| Captor Therapeutics Spolka Akcyjna | 447.83M |
| Bioceltix | 393.96M |
| BIOTON | 347.75M |
| Synthaverse | 284.50M |
| Mabion | 133.34M |
| Poltreg | 120.32M |
| Urteste | 98.96M |